Anthony Casarez
Seminars
Tuesday 21st July 2026
Roundtable Discussion – Designing the Ideal Radioligand Therapy by Integrating Isotope, Chelator, & Targeting Moiety Selection
11:30 am
Pull up a chair for this high-energy collaborative session where you will join your industry peers to dissect the “Holy Trinity” of RLT design and solve complex integration puzzles. It’s time to trade insights, challenge traditional selection criteria, and then share your group’s top 3 thoughts and discussion points back to the room!
- Bringing together preclinical and early clinical perspectives to explore how to optimize RLT design for efficacy, safety, and translational readiness
- Balancing isotope properties, emission type, and half-life with clinical objectives
- Selecting chelation strategies to ensure stability, delivery, and safety
- Matching targeting moieties to tumor biology and therapeutic goals
Thursday 23rd July 2026
Engineering High-Fidelity Theranostic Pairs with Covalent Radiohalogens (F-18/I-131/At-211) to Improve Biodistributi
11:30 am
- Designing covalent radiohalogen therapeutics with matched diagnostic–therapeutic pairs to improve predictive biodistribution and translational confidence
- Overcoming traditional limitations of chelated radiometals by reducing off-target accumulation and enabling blood-brain barrier penetration
- Presenting preclinical imaging and efficacy data showing remarkable tumor control and favorable safety profiles across small molecule and bioligand-tagged platforms
